📊 Score Breakdown
Offering Ability
40
Cash Runway
10
Float Risk
5
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for GPRE.
💹 Market Data
Market Cap$1.10B
Shares Outstanding70.03M
Float67.60M
Cash$95.72M
Debt$558.76M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 10.7% shares (2025Q4 vs prior)
217 institutional holders · 79.99M shares
#1
BlackRock, Inc.
6.93M shares
#2
VANGUARD GROUP INC
4.70M shares
#3
Grantham, Mayo, Van Otterloo & Co. LLC
4.03M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest12.86M
Days to Cover7.3
% of Float19.0%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2025
xbrl
XBRL CONVERTIBLE
Dec 31, 2024
4
INSIDER TRANSACTION
Mar 16, 2026
4
INSIDER TRANSACTION
Mar 16, 2026
4
INSIDER TRANSACTION
Mar 16, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for GPRE
📊 GPRE FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 GPRE Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.